Biochemistry and suicidal behavior in depressed patients

Area of Science:

• Neurobiology
• Psychiatry
• Clinical Psychology

Background:

• Suicidal behavior in depressed patients is a significant concern.
• Previous research suggests links between monoamine levels, hypothalamic-pituitary-adrenocortical (HYPAC) axis function, and suicidal behavior.
• Inconsistent findings necessitate further investigation into these relationships.

Purpose of the Study:

• To explore the relationship between monoamine levels and HYPAC functioning in depressed patients with suicidal behavior.
• To identify biological markers associated with suicide attempts in major depression.

Main Methods:

• Study involved 132 depressed inpatients from the NIMH Collaborative Study on the Psychobiology of Depression.
• Assessed monoamine levels (e.g., 5-HIAA, MHPG) in cerebrospinal fluid (CSF), plasma, and urine.
• Evaluated HYPAC functioning through cortisol levels and Dexamethasone Suppression Test (DST).

Main Results:

• Suicide attempters were younger, more bipolar, had earlier onset, and more psychotic features.
• No correlation found between cortisol hypersecretion or DST nonsuppression and suicide attempts.
• Lower pre-DST evening plasma cortisol was observed in attempters.
• CSF 5-hydroxyindoleacetic acid (5-HIAA) did not correlate with suicide attempts.
• Lower urinary and plasma 3-methoxy-4-hydroxphenylglycol (MHPG) levels were found in attempters, particularly in the bipolar subgroup.

Conclusions:

• Reduced MHPG levels may be a biological correlate of suicidal behavior in depressed patients, especially those with bipolar disorder.
• Evening plasma cortisol may offer some discriminative value, but HYPAC axis function is not a primary correlate of suicide attempts in this cohort.
• Further research is needed to elucidate the complex neurobiological underpinnings of suicidal behavior in depression.